These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 8388606
1. Value and limitations of cytologic criteria for the diagnosis of hepatocellular carcinoma by fine needle aspiration biopsy. Solé M, Calvet X, Cuberes T, Maderuelo F, Bruix J, Bru C, Rey MJ, Serna N, Cardesa A. Acta Cytol; 1993; 37(3):309-16. PubMed ID: 8388606 [Abstract] [Full Text] [Related]
8. Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver. Lin F, Abdallah H, Meschter S. Diagn Cytopathol; 2004 Feb 25; 30(2):92-7. PubMed ID: 14755758 [Abstract] [Full Text] [Related]
10. Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration cytology. Saad RS, Luckasevic TM, Noga CM, Johnson DR, Silverman JF, Liu YL. Diagn Cytopathol; 2004 Jan 25; 30(1):1-6. PubMed ID: 14696137 [Abstract] [Full Text] [Related]
11. Cytomorphology of combined hepatocellular-cholangiocarcinoma in fine needle aspirates of the liver. A report of two cases. Kilpatrick SE, Geisinger KR, Loggie BW, Hopkins MB. Acta Cytol; 1993 Jan 25; 37(6):943-7. PubMed ID: 7504382 [Abstract] [Full Text] [Related]
13. Discriminating hepatocellular carcinoma from metastatic carcinoma on fine-needle aspiration biopsy of the liver: the utility of immunocytochemical panel. Saleh HA, Aulicino M, Zaidi SY, Khan AZ, Masood S. Diagn Cytopathol; 2009 Mar 25; 37(3):184-90. PubMed ID: 19170172 [Abstract] [Full Text] [Related]